Diabetes News

Endocrinology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Brauker J et al. - Ambulatory sensors are currently approved and used only to treat insulin-using diabetes patients. In the future, the technology may have benefit for diagnostic use and behavior modification in obesity, metabolic syndrome, and prediabetes, as well as metabolic monitoring in elite athletes, soldiers, pilots, and the like. Hospitals currently use single-point information for tracking glucose in patients. Blood-based continuous sensing may provide the data needed to prevent in-hospital hypoglycemia and may lead to closed loop technology in the hospital.

 

Related Articles

Decaffeinated coffee and glucose metabolism in young men
Diabetes Care, 11/18/09    Relevance Score: 46%

Interference Studies with Two Hospital-Grade and Two Home-Grade Glucose Meters
Diabetes Technology & Therapeutics, 10/16/09    Relevance Score: 46%

Contribution of skeletal muscle mass on sex differences in 2-hour plasma glucose levels after oral glucose load in Thai subjects with normal glucose tolerance
Metabolism-Clinical and Experimental, 10/09/09    Relevance Score: 46%

Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran
Diabetes/Metabolism Research and Reviews, 10/30/09    Relevance Score: 45%

Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
Cochrane Reviews, 10/19/09    Relevance Score: 45%